Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-antibiotic therapy in children with chronic abdominal pain and Helicobacter pylori infection
ChiCTR2200062024Phase 4Not yet recruiting
- Sponsor
- Shanxi Bethune Hospital
- Start
- Jul 2022
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of clostridium butyricum, bacillus coagulans and lamb stomach extract + vitamin B12 in chronic abdominal pain (CAP) and Helicobacter pylori infection (4 arms), sponsored by Shanxi Bethune Hospital. Primary endpoint: effective rate of chronic abdominal pain. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
clostridium butyricumbacillus coagulanslamb stomach extract + vitamin B12
03
Conditions
chronic abdominal pain (CAP)Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2200062024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062024.